Published in Immunology on February 01, 1995
The anticancer immune response: indispensable for therapeutic success? J Clin Invest (2008) 4.01
Androgen ablation mitigates tolerance to a prostate/prostate cancer-restricted antigen. Cancer Cell (2005) 2.37
Androgen ablation augments prostate cancer vaccine immunogenicity only when applied after immunization. Prostate (2009) 1.19
Clinical strategies to enhance T cell reconstitution. Semin Immunol (2007) 1.11
Prostate cancer patients on androgen deprivation therapy develop persistent changes in adaptive immune responses. Hum Immunol (2010) 1.08
Sex, glia, and development: interactions in health and disease. Horm Behav (2012) 1.01
The effect of testosterone replacement treatment on immunological features of patients with Klinefelter's syndrome. Clin Exp Immunol (2000) 1.01
Bone marrow stromal cells mediate androgenic suppression of B lymphocyte development. J Clin Invest (2001) 0.93
Increased CD8+ T-cell function following castration and immunization is countered by parallel expansion of regulatory T cells. Cancer Res (2012) 0.91
Susceptibility to autoimmunity and B cell resistance to apoptosis in mice lacking androgen receptor in B cells. Mol Endocrinol (2009) 0.90
Visualising androgen receptor activity in male and female mice. PLoS One (2013) 0.89
Androgen receptor (AR) pathophysiological roles in androgen-related diseases in skin, bone/muscle, metabolic syndrome and neuron/immune systems: lessons learned from mice lacking AR in specific cells. Nucl Recept Signal (2013) 0.88
Sex differences in neurodevelopmental and neurodegenerative disorders: Focus on microglial function and neuroinflammation during development. J Steroid Biochem Mol Biol (2015) 0.86
Thymic rejuvenation and aging. Curr Opin Immunol (2013) 0.86
Gonadotropin treatment restores in vitro interleukin-1beta and tumour necrosis factor-alpha production by stimulated peripheral blood mononuclear cells from patients with idiopathic hypogonadotropic hypogonadism. Clin Exp Immunol (2003) 0.85
Effect of sex steroids on Babesia microti infection in mice. Am J Trop Med Hyg (2012) 0.84
Targeting thymic epithelia AR enhances T-cell reconstitution and bone marrow transplant grafting efficacy. Mol Endocrinol (2012) 0.82
A randomized phase II trial evaluating different schedules of zoledronic acid on bone mineral density in patients with prostate cancer beginning androgen deprivation therapy. Clin Genitourin Cancer (2013) 0.80
Adverse Reproductive and Developmental Health Outcomes Following Prenatal Exposure to a Hydraulic Fracturing Chemical Mixture in Female C57Bl/6 Mice. Endocrinology (2016) 0.79
Differential suppressive effects of testosterone on immune function in fresh water snake, Natrix piscator: an in vitro study. PLoS One (2014) 0.79
Prediction of treatment efficacy for prostate cancer using a mathematical model. Sci Rep (2016) 0.78
Sex hormones modulate the immune response to Plasmodium berghei ANKA in CBA/Ca mice. Parasitol Res (2015) 0.78
Effects of transdermal testosterone treatment on inflammatory markers in elderly males. Endocr Pract (2014) 0.77
Transcriptional responses of PBMC in psychosocially stressed animals indicate an alerting of the immune system in female but not in castrated male pigs. BMC Genomics (2014) 0.76
Targeting the androgen receptor in triple-negative breast cancer: current perspectives. Onco Targets Ther (2017) 0.75
TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol (1989) 31.72
The "Ly-1 B" cell subpopulation in normal immunodefective, and autoimmune mice. J Exp Med (1983) 5.74
Studies of the regulatory effects of the sex hormones on antibody formation and stem cell differentiation. J Exp Med (1972) 2.44
Identification of a B cell differentiation factor(s) spontaneously produced by proliferating T cells in murine lupus strains of the lpr/lpr genotype. J Exp Med (1983) 2.15
Estrogen regulates the IFN-gamma promoter. J Immunol (1991) 1.91
Molecular aspects of B-lymphocyte activation. Annu Rev Cell Biol (1987) 1.49
Dihydrotestosterone exerts a depressive influence on the production of interleukin-4 (IL-4), IL-5, and gamma-interferon, but not IL-2 by activated murine T cells. Blood (1991) 1.49
The influence of sex upon the antibody response to an incompatible tumour. Immunology (1965) 1.38
Sex hormone regulation of in vitro immune response. Estradiol enhances human B cell maturation via inhibition of suppressor T cells in pokeweed mitogen-stimulated cultures. J Exp Med (1981) 1.31
B cell subsets and differential responses to mitogens. Immunol Rev (1982) 1.26
Sex-associated differences in the regulation of immune responses controlled by the MHC of the mouse. J Immunol (1984) 1.16
Estrogen induces normal murine CD5+ B cells to produce autoantibodies. J Immunol (1989) 1.14
A sensitive solid phase microradioimmunoassay for anti-double stranded DNA antibodies. Arthritis Rheum (1981) 1.12
Influence of castration, alone or combined with thymectomy, on the development of diabetes in the nonobese diabetic mouse. Endocrinology (1991) 1.11
Preferential autoantibody reactivity of the preimmune B cell repertoire in normal mice. J Immunol (1988) 1.08
Androgen deprivation induces phenotypic and functional changes in the thymus of adult male mice. Endocrinology (1991) 1.06
Induction of immature thymocyte proliferation after castration of normal male mice. Endocrinology (1994) 0.94
Conventional B cells, not B1 cells, are the source of autoantibodies in chronic graft-versus-host disease. J Immunol (1993) 0.93
Hormonal modulation of responses to thymus-independent and thymus-dependent antigens in autoimmune NZB/W mice. J Immunol (1985) 0.88
Effect of endogenous androgens on lymphocyte subpopulations. Lancet (1985) 0.83
Beneficial effect of testosterone in the treatment of chronic autoimmune thyroiditis in rats. J Immunol (1986) 0.79
Vascular permeability factor/endothelial growth factor (VPF/VEGF): accumulation and expression in human synovial fluids and rheumatoid synovial tissue. J Exp Med (1994) 2.54
Protein array autoantibody profiles for insights into systemic lupus erythematosus and incomplete lupus syndromes. Clin Exp Immunol (2007) 2.51
Gonadal steroids and immunity. Endocr Rev (1996) 2.25
HLA-DR alleles with naturally occurring amino acid substitutions and risk for development of rheumatoid arthritis. Arthritis Rheum (1990) 1.90
Multicenter study of recombinant human erythropoietin in correction of anemia in rheumatoid arthritis. Am J Med (1990) 1.79
Alterations in the regulation of androgen-sensitive Cyp 4a monooxygenases cause hypertension. Proc Natl Acad Sci U S A (2001) 1.61
Self-report questionnaire scores in rheumatoid arthritis compared with traditional physical, radiographic, and laboratory measures. Ann Intern Med (1989) 1.57
Transforming growth factor beta 1 (TGF-beta 1) induced neutrophil recruitment to synovial tissues: implications for TGF-beta-driven synovial inflammation and hyperplasia. J Exp Med (1991) 1.55
Androgen receptors in thymic epithelium modulate thymus size and thymocyte development. Endocrinology (2001) 1.53
Immunologic studies of rheumatoid arthritis patients treated with methotrexate. Arthritis Rheum (1987) 1.34
Androgens accelerate thymocyte apoptosis. Endocrinology (1998) 1.21
Interferon signature gene expression is correlated with autoantibody profiles in patients with incomplete lupus syndromes. Clin Exp Immunol (2009) 1.21
Malignant pleural and peritoneal mesotheliomas in former miners and millers of crocidolite at Wittenoom, Western Australia. Occup Environ Med (2004) 1.14
Molecular basis of an autoantibody-associated restriction fragment length polymorphism that confers susceptibility to autoimmune diseases. J Clin Invest (1991) 1.12
Persistence of intracellular HIV-1 mRNA correlates with HIV-1-specific immune responses in infected subjects on stable HAART. AIDS (2001) 1.11
Androgen receptors in human thymocytes. J Immunol (1987) 1.10
Effects of androgens on T and B lymphocyte development. Immunol Res (2001) 1.07
Androgen deprivation induces phenotypic and functional changes in the thymus of adult male mice. Endocrinology (1991) 1.06
Vitamin A and cancer prevention I: observations in workers previously exposed to asbestos at Wittenoom, Western Australia. Int J Cancer (1998) 1.04
HLA-DR4 and other genetic markers in rheumatoid arthritis. Br J Rheumatol (1988) 1.04
A mutation that causes lability of the androgen receptor under conditions that normally promote transformation to the DNA-binding state. J Clin Invest (1984) 1.02
Treatment of the anemia of predialysis patients with recombinant human erythropoietin: a randomized, placebo-controlled trial. Am J Med Sci (1988) 1.01
Testosterone induces expression of transforming growth factor-beta 1 in the murine thymus. J Steroid Biochem Mol Biol (1993) 1.00
A highly informative probe for two polymorphic Vh gene regions that contain one or more autoantibody-associated Vh genes. J Clin Invest (1989) 0.98
Anti-centromere antibodies (ACA) in systemic sclerosis patients and their relatives: a serological and HLA study. Clin Exp Immunol (1994) 0.97
Androgens alter B cell development in normal male mice. Cell Immunol (1997) 0.97
Scleroderma is associated with differences in individual routes of drug metabolism: a study with dapsone, debrisoquin, and mephenytoin. Clin Pharmacol Ther (1990) 0.96
Possible deletion of a developmentally regulated heavy-chain variable region gene in autoimmune diseases. Proc Natl Acad Sci U S A (1990) 0.96
Induction of immature thymocyte proliferation after castration of normal male mice. Endocrinology (1994) 0.94
Mortality of former crocidolite (blue asbestos) miners and millers at Wittenoom. Occup Environ Med (2007) 0.94
Class II human leukocyte antigen genes and T cell receptor polymorphisms in patients with rheumatoid arthritis. Am J Med (1988) 0.94
Bone marrow stromal cells mediate androgenic suppression of B lymphocyte development. J Clin Invest (2001) 0.93
Schistosoma mansoni: susceptibility differences between male and female mice can be mediated by testosterone during early infection. Exp Parasitol (1997) 0.92
Determining risk factors for developing systemic lupus erythematosus in patients with discoid lupus erythematosus. Br J Dermatol (2011) 0.92
Case report: testosterone treatment of systemic lupus erythematosus in a patient with Klinefelter's syndrome. Am J Med Sci (1995) 0.92
The inhibition of progesterone secretion and the regulation of cyclic nucleotides by atrial natriuretic factor in gonadotropin responsive murine Leydig tumor cells. Biochem Biophys Res Commun (1985) 0.91
Use of P-31 magnetic resonance spectroscopy to detect metabolic abnormalities in muscles of patients with fibromyalgia. Arthritis Rheum (1998) 0.91
Immunochemical and flow cytometric analysis of androgen receptor expression in thymocytes. Mol Cell Endocrinol (1995) 0.90
Schistosoma mansoni: mortality, pathophysiology, and susceptibility differences in male and female mice. Exp Parasitol (1992) 0.88
From human autoantibodies to the fetal antibody repertoire to B cell malignancy: it's a small world after all. Int Rev Immunol (1990) 0.88
Malignant mesotheliomas in former miners and millers of crocidolite at Wittenoom (Western Australia) after more than 50 years follow-up. Br J Cancer (2012) 0.88
Decreased pokeweed mitogen-induced IgM and IgM rheumatoid factor synthesis in rheumatoid arthritis patients treated with gold sodium thiomalate or penicillamine. Arthritis Rheum (1984) 0.88
Treatment of the anemia of rheumatoid arthritis with recombinant human erythropoietin: clinical and in vitro studies. Arthritis Rheum (1989) 0.87
Utility of magnetic resonance imaging in the evaluation of patients with inflammatory myopathies. Curr Rheumatol Rep (2001) 0.86
Studies of immunological function in mice with defective androgen action. Distinction between alterations in immune function due to hormonal insensitivity and alterations due to other genetic factors. Immunology (1991) 0.86
Gene-expression signatures: biomarkers toward diagnosing multiple sclerosis. Genes Immun (2011) 0.85
Glucocorticoid receptor structure and function in an adrenocorticotropin-secreting small cell lung cancer. Mol Endocrinol (1995) 0.85
Highly conserved gene expression profiles in humans with allergic rhinitis altered by immunotherapy. Clin Exp Allergy (2005) 0.85
HLA-DPB1*0301 is a major risk factor for rheumatoid factor-negative adult rheumatoid arthritis. Arthritis Rheum (1991) 0.84
Atrial natriuretic factor regulates steroidogenic responsiveness and cyclic nucleotide levels in mouse Leydig cells in vitro. Biochem Biophys Res Commun (1986) 0.84
Effects of administration of an anti-CD5 plus immunoconjugate in rheumatoid arthritis. Results of two phase II studies. The CD5 Plus Rheumatoid Arthritis Investigators Group. Arthritis Rheum (1993) 0.84
Treatment of rheumatoid arthritis with a DR4/1 peptide. J Rheumatol (2000) 0.83
Use of magnetic resonance imaging and P-31 magnetic resonance spectroscopy to detect and quantify muscle dysfunction in the amyopathic and myopathic variants of dermatomyositis. Arthritis Rheum (1995) 0.83
Increased thymic size and thymocyte interleukin 2 production in androgen-resistant mice. Scand J Immunol (1989) 0.83
Population and family studies of three disease-related polymorphic genes in systemic lupus erythematosus. J Clin Invest (1995) 0.82
25-Hydroxyvitamin D levels in African-American and Caucasian/Hispanic subjects with cutaneous lupus erythematosus. Br J Dermatol (2012) 0.82
Decreased T-cell-mediated suppression of IgM--rheumatoid factor synthesis in rheumatoid arthritis. Clin Immunol Immunopathol (1987) 0.81
Determination of the lethal dose of dexamethasone for early passage in vitro human glioblastoma cell cultures. Neurosurgery (1993) 0.81
High levels of in vitro IgM rheumatoid factor synthesis correlate with HLA-DR4 in normal individuals. Arthritis Rheum (1987) 0.81
Analysis of the androgen receptor in isolated testicular cell types with a microassay that uses an affinity ligand. Endocrinology (1989) 0.81
Evaluation of muscles in a patient with suspected amyopathic dermatomyositis by magnetic resonance imaging and phosphorus-31-spectroscopy. J Am Acad Dermatol (1994) 0.81
Revision of failed total hip arthroplasty. J Bone Joint Surg Br (1987) 0.80
Transformation of human androgen receptors to the deoxyribonucleic acid-binding state. Endocrinology (1983) 0.80
Muscle abnormalities in juvenile dermatomyositis patients: P-31 magnetic resonance spectroscopy studies. Arthritis Rheum (2000) 0.79
Synthesis of rheumatoid factor in vitro: implications for the pathogenesis of rheumatoid arthritis. Semin Arthritis Rheum (1985) 0.79
The changing ratio of serum bioactive to immunoreactive follicle-stimulating hormone in normal men following treatment with a potent gonadotropin releasing hormone antagonist. J Clin Endocrinol Metab (1986) 0.79
Chest pain in asbestos-exposed individuals with benign pleural and parenchymal disease. Am J Respir Crit Care Med (2000) 0.78
Magnetic resonance imaging and P-31 magnetic resonance spectroscopy provide unique quantitative data useful in the longitudinal management of patients with dermatomyositis. Arthritis Rheum (1994) 0.78
Estrogen and androgen production rates in two brothers with Reifenstein syndrome. J Clin Endocrinol Metab (1990) 0.78
An ACTH-producing small cell lung cancer expresses aberrant glucocorticoid receptor transcripts from a normal gene. Mol Cell Endocrinol (1998) 0.77
Effect of methysergide and dihydroergotamine on Schistosoma mansoni. J Pharmacol Exp Ther (1974) 0.77
No dose-dependent increase in fracture risk after long-term exposure to high doses of retinol or beta-carotene. Osteoporos Int (2012) 0.77
Elevated IgG autoantibody production in oligoarticular juvenile idiopathic arthritis may predict a refractory course. Clin Exp Rheumatol (2011) 0.77
Androgen resistance in man. Adv Exp Med Biol (1986) 0.77
Suppression of pituitary-gonadal function by a potent new luteinizing hormone-releasing hormone antagonist in normal men. J Clin Endocrinol Metab (1987) 0.76
Revision of the uncemented hip prosthesis. Acta Orthop Scand (1987) 0.76
Associations of IgA and IgA-rheumatoid factor with disease features in patients with rheumatoid arthritis. Immunol Invest (1994) 0.76
St Georg modular knee prosthesis. A two-and-a-half to six-year follow-up. J Bone Joint Surg Br (1986) 0.75
Adult nephroblastoma. Scand J Urol Nephrol (1977) 0.75
Fear of success-fact or artifact? J Psychol (1978) 0.75
Function of a truncated glucocorticoid receptor form at a negative glucocorticoid response element in the proopiomelanocortin gene. J Mol Endocrinol (2001) 0.75
Expression of 11beta-hydroxysteroid dehydrogenase type 2 in an ACTH-producing small cell lung cancer. J Steroid Biochem Mol Biol (1998) 0.75
Relationship between in vitro IgM rheumatoid factor (RF) synthesis and the response to gold therapy in rheumatoid arthritis (RA) patients. Arthritis Rheum (1985) 0.75
Cushing's syndrome due to adrenal adenoma with persistent diurnal cortisol secretory rhythm. Metabolism (1978) 0.75
[Laparoscopic ventrosuspension]. Ugeskr Laeger (1982) 0.75
Isolation and characterization of an early T-helper/inducer cell line with a unique pattern of surface phenotype, constitutive cytokine secretion and myc oncogene expression. Leukemia (1993) 0.75
[Intestinal explosion during the use of diathermy]. Ugeskr Laeger (1978) 0.75
Quantitative evaluation of improvement in muscle weakness in a patient receiving extracorporeal photopheresis for scleroderma: magnetic resonance imaging and magnetic resonance spectroscopy. J Am Acad Dermatol (1995) 0.75
Gonadotropins and testosterone escape from suppression during prolonged luteinizing hormone-releasing hormone antagonist administration in normal men. J Clin Endocrinol Metab (1987) 0.75
[Eclampsia in hydatiform mole]. Ugeskr Laeger (1981) 0.75
[Bilateral sclerosing osteitis in the clavicle]. Ugeskr Laeger (1986) 0.75
Evaluation of muscle diseases using artificial neural network analysis of 31P MR spectroscopy data. Magn Reson Med (1995) 0.75
St. Georg hinged-knee prosthesis. A 2.5- to 8-year follow-up. Arch Orthop Trauma Surg (1985) 0.75